Core Insights - The world's first drug manufacturing system suitable for ADC (Antibody-Drug Conjugates) and nucleotide monomer synthesis was officially launched in Shanghai [1] - This system, developed by Ruizhi Pharmaceutical in collaboration with East China Normal University, utilizes femtosecond laser technology to carve complex chemical factories on chips [1] - The system is expected to usher the pharmaceutical industry into a new era of continuous, miniaturized, and intelligent manufacturing [1] Cost and Efficiency - The new system significantly shortens the drug development cycle and reduces the cost of nucleotide monomer synthesis by over 40% [1] - It addresses issues related to expensive raw materials and long reaction times inherent in traditional processes [1] Future Implications - The future of drug production is anticipated to shift towards "on-demand intelligent manufacturing," moving away from reliance on centralized large factories [1] - Production may become decentralized, extending to hospitals, communities, and even households [1]